Metropolitan Life Insurance Company (MetLife)’s Aligos Therapeutics ALGS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-260	Closed	-$77.2K	–	2259
2021 Q4	$77.2K	Hold	260	–	–	﹤0.01%	2604
2021 Q3	$101K	Buy	+260	New	+$101K	﹤0.01%	2509